Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study
出版年份 2018 全文链接
标题
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROLOGY
Volume 26, Issue 2, Pages 363-370
出版商
Wiley
发表日期
2018-10-09
DOI
10.1111/ene.13824
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
- (2017) Tomas Kalincik et al. LANCET NEUROLOGY
- Treatment decisions in multiple sclerosis — insights from real-world observational studies
- (2017) Maria Trojano et al. Nature Reviews Neurology
- Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS
- (2017) Johannes Lorscheider et al. NEUROLOGY
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study
- (2016) Marcus D’Souza et al. Multiple Sclerosis Journal
- Data quality evaluation for observational multiple sclerosis registries
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Observational data: Understanding the real MS world
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study
- (2016) Marcus D’Souza et al. Multiple Sclerosis Journal
- Data quality evaluation for observational multiple sclerosis registries
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Observational data: Understanding the real MS world
- (2016) Tomas Kalincik et al. Multiple Sclerosis Journal
- Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
- (2015) Tomas Kalincik et al. ANNALS OF NEUROLOGY
- Defining reliable disability outcomes in multiple sclerosis
- (2015) Tomas Kalincik et al. BRAIN
- MatchIt: Nonparametric Preprocessing for Parametric Causal Inference
- (2015) Daniel E. Ho et al. Journal of Statistical Software
- Modelling the natural history of primary progressive multiple sclerosis
- (2014) Katharine E Harding et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Progressive multiple sclerosis: desperately seeking remedy
- (2013) Olaf Stuve et al. LANCET NEUROLOGY
- Treatment trials in progressive MS—current challenges and future directions
- (2013) Marcus W. Koch et al. Nature Reviews Neurology
- Treatment of relapsing-remitting multiple sclerosis
- (2012) Aaron E. Miller et al. CURRENT OPINION IN NEUROLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis
- (2010) S. Belachew et al. EUROPEAN JOURNAL OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- The natural history of primary progressive multiple sclerosis
- (2009) M. Koch et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started